Literature DB >> 24831493

HIV drug resistance in newly diagnosed adults in a rural prefecture of eastern China.

J Hua1, H Lin1, Y Ding1, D Qiu2, F Wong3, N He1.   

Abstract

Little is known about HIV drug resistance (HIVDR) in newly diagnosed HIV-infected adults in eastern China where the HIV epidemic is spreading predominantly through sexual contact. During 2008-2011, newly HIV-diagnosed adults in Taizhou prefecture, Zhejiang province in eastern China were examined for HIVDR by amplifying and sequencing the HIV-1 pol gene. Of 447 genotyped participants, 53·7% were infected with CRF01_AE, 20·1% with CRF07_BC, 12·5% with subtype B, and 11·6% with CRF08_BC. Most of the participants had one or more minor genetic mutations in the pol gene that are associated with HIVDR. Twelve (2·7%) participants met the standard guidelines of having low to high HIVDR, suggesting that the prevalence of HIVDR in newly HIV-diagnosed adults was low in the study area and current antiretroviral therapy (ART) regimens are likely to remain effective. However, given high frequency of minor HIVDR in HIV patients and the scaling up of ART programmes in China, larger HIVDR surveillance programmes are needed.

Entities:  

Keywords:  Antiretroviral therapy (ART); China; HIV drug resistance; transmission

Mesh:

Substances:

Year:  2014        PMID: 24831493      PMCID: PMC9507063          DOI: 10.1017/S0950268814001174

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  35 in total

1.  The prevalence of drug resistance mutations among treatment-naive HIV-infected individuals in Beijing, China.

Authors:  Jing-rong Ye; Hong-yan Lu; Wei-shi Wang; Lei Guo; Ruo-lei Xin; Shuang-qing Yu; Ting-chen Wu; Yi Zeng; Xiong He
Journal:  AIDS Res Hum Retroviruses       Date:  2011-08-10       Impact factor: 2.205

2.  Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen.

Authors:  J L Casado; K Hertogs; L Ruiz; F Dronda; A Van Cauwenberge; A Arnó; I Garcia-Arata; S Bloor; A Bonjoch; J Blazquez; B Clotet; B Larder
Journal:  AIDS       Date:  2000-01-28       Impact factor: 4.177

3.  Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.

Authors:  Karin J Metzner; Pia Rauch; Hauke Walter; Christoph Boesecke; Bernhard Zöllner; Heiko Jessen; Knud Schewe; Stefan Fenske; Holger Gellermann; Hans-Jürgen Stellbrink
Journal:  AIDS       Date:  2005-11-04       Impact factor: 4.177

4.  The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China.

Authors:  Fujie Zhang; Zhihui Dou; Lan Yu; Jiahong Xu; Jin Hua Jiao; Ning Wang; Ye Ma; Yan Zhao; Hongxin Zhao; Ray Y Chen
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

5.  Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment.

Authors:  Diane E Bennett; Mark Myatt; Silvia Bertagnolio; Donald Sutherland; Charles F Gilks
Journal:  Antivir Ther       Date:  2008

6.  Resistance of HIV-1 to multiple antiretroviral drugs in France: a 6-year survey (1997-2002) based on an analysis of over 7000 genotypes.

Authors:  Catherine Tamalet; Jacques Fantini; Christian Tourres; Nouara Yahi
Journal:  AIDS       Date:  2003-11-07       Impact factor: 4.177

Review 7.  Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

Authors:  M S Hirsch; B Conway; R T D'Aquila; V A Johnson; F Brun-Vézinet; B Clotet; L M Demeter; S M Hammer; D M Jacobsen; D R Kuritzkes; C Loveday; J W Mellors; S Vella; D D Richman
Journal:  JAMA       Date:  1998-06-24       Impact factor: 56.272

8.  Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.

Authors:  J Liu; J Yue; S Wu; Y Yan
Journal:  Arch Virol       Date:  2007-07-06       Impact factor: 2.574

9.  Five-year outcomes of the China National Free Antiretroviral Treatment Program.

Authors:  Fujie Zhang; Zhihui Dou; Ye Ma; Yan Zhao; Zhongfu Liu; Marc Bulterys; Ray Y Chen
Journal:  Ann Intern Med       Date:  2009-08-18       Impact factor: 25.391

10.  Molecular epidemiology of human immunodeficiency virus type 1 in Guangdong province of southern China.

Authors:  Song Chen; Weiping Cai; Jingyang He; Nicole Vidal; Chunhui Lai; Weizhong Guo; Haolan He; Xiejie Chen; Linchun Fu; Linsheng Fu; Martine Peeters; Eric Delaporte; Jean-Marie Andrieu; Wei Lu
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

View more
  3 in total

Review 1.  Evolving HIV Epidemiology in Mainland China: 2009-2018.

Authors:  Yingying Ding; Zhonghui Ma; Jiayu He; Xiaoyi Xu; Shijie Qiao; Lulu Xu; Ruizi Shi; Xiaohui Xu; Bowen Zhu; Jing Li; Frank Y Wong; Na He
Journal:  Curr HIV/AIDS Rep       Date:  2019-12       Impact factor: 5.071

2.  The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012-2014.

Authors:  Peibin Zeng; Yu Liu; Miao He; Jingxing Wang; Sheila Keating; Wei Mao; Mei Huang; Hongli Ma; Weilan He; Xinhong Bi; Dan Liao; Michael Busch; Paul Ness; Jing Liu; Hua Shan
Journal:  PLoS One       Date:  2017-06-16       Impact factor: 3.240

3.  Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China.

Authors:  Lei Liu; Aobo Dong; Lingjie Liao; Yi Feng; Yiming Shao; Shu Liang; Yuhua Ruan; Hui Xing
Journal:  Curr HIV Res       Date:  2019       Impact factor: 1.581

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.